Establishment Labs Inc. (ESTA)
| Bid | 44 |
| Market Cap | 1.3B |
| Revenue (ttm) | 177.42M |
| Net Income (ttm) | -88.52M |
| EPS (ttm) | -3.08 |
| PE Ratio (ttm) | -14.56 |
| Forward PE | -37.08 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 46.88 |
| Volume | 709,980 |
| Avg. Volume (20D) | 344,053 |
| Open | 44.95 |
| Previous Close | 44.40 |
| Day's Range | 44.22 - 46.86 |
| 52-Week Range | 26.56 - 50.85 |
| Beta | 0.86 |
| Ex-Dividend Date | n/a |
About ESTA
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for ESTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAnalysts project revenue of ... Unlock content with Pro Subscription
2 months ago · seekingalpha.com
Establishment Labs Holdings Inc. (ESTA) Q2 2025 Earnings Call TranscriptEstablishment Labs Holdings Inc. (NASDAQ:ESTA ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Fillipo Peter Caldini - CEO & Director Rajbir Singh Denhoy - Chief Finan...
2 months ago · businesswire.com
Establishment Labs Reports Second Quarter 2025 Financial ResultsNEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
2 months ago · businesswire.com
Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...